Showing results (691-700 of 8,523) with videos related to

Sort By:
Pageof 853
Alimentary Pharmacology & Therapeutics|August 29, 2002
Review article: lactose--a potential prebioticA Szilagyi
Alimentary Pharmacology & Therapeutics|August 29, 2002
Meta-analysis: combination therapy with interferon-alpha 2a/2b and ribavirin for patients with chronic hepatitis C previously non-responsive to interferonR San Miguel, F Guillén, J M Cabasés, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2002
Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis CG B Gaeta, D F Precone, F M Felaco, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2002
A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsiaG Holtmann, J Gschossmann, P Mayr, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2002
Dynamics of Helicobacter pylori infection in early childhood in a high-risk group living in Germany: loss of infection higher than acquisitionD Rothenbacher, G Bode, H Brenner
Alimentary Pharmacology & Therapeutics|August 29, 2002
Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradicationB-S Sheu, J-J Wu, C-Y Lo, et al.
Alimentary Pharmacology & Therapeutics|December 12, 2001
Systematic review: the use of somatostatin or octreotide in refractory diarrhoeaA Szilagyi, I Shrier
Alimentary Pharmacology & Therapeutics|December 12, 2001
A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcerA Leodolter, M Kulig, H Brasch, et al.
Alimentary Pharmacology & Therapeutics|December 12, 2001
Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infectionB C Wong, W M Wong, Y K Yee, et al.
Alimentary Pharmacology & Therapeutics|December 12, 2001
Gut mucosal uptake and retention characteristics contribute to the high intestinal selectivity of budesonide compared with prednisolone in the ratA Miller-Larsson, B Gustafsson, C G Persson, et al.
Pageof 853